Dr. Harsh Vardhan, Union Minister for Science & Technology, Health and Family Welfare and Earth Sciences released the white paper on ‘Focused Interventions for ‘Make in India’: Post COVID 19’ prepared by TIFAC, at a virtual function in Nirman Bhavan, New Delhi today(10.07.2020). Dr. V K Saraswat, Chairman TIFAC Governing Council, and Prof. Pradeep Srivastava, Executive Director, TIFAC along with Shri. Sanjay Singh, Scientist ‘G’ and Shri Mukesh Mathur, In-charge (F&A), TIFAC were also present on the occasion. The TIFAC Report on “Active Pharmaceutical Ingredients: Status, Issues, Technology Readiness and Challenges” was also released by the Hon’ble Minister during this occasion.
Dr. Harsh Vardhan congratulated TIFAC “for bringing out this White Paper document at a right time when India is gearing up for boosting economy with a new Mantra “Local Solutions to Global Challenges – Policy and Technology Imperatives”. “The road to national economy recovery would traverse through measures like Policy support to unconventional strategies, leveraging into new international partnerships in important sectors of Agriculture, Electronics, Health, ICT and Manufacturing and providing new technology stimulus”, he added. Dr. Harsh Vardhan requested “our Industry friends, Research and Policy Bodies to refer this White Paper in designing the path for upliftment of economy.”
The white paper has analyzed the impact of COVID-19 during this financial year on various sectors and COVID impact on demand and supply.
TIFAC White Paper has flagged the need for indigenous production of those Active Pharmaceutical Ingredients (APIs) for which our country is majorly dependent on imports from China.